LRG1

LRG1
Identifiers
Aliases	LRG1 , HMFT1766, LRG, leucine-rich alpha-2-glycoprotein 1, leucine rich alpha-2-glycoprotein 1, LGR-1
External IDs	OMIM: 611289 MGI: 1924155 HomoloGene: 36468 GeneCards: LRG1
Gene location (Human)
Chr.	Chromosome 19 (human)
End	4,540,036 bp
Gene location (Mouse)
Chr.	Chromosome 17 (mouse)
End	56,429,001 bp
RNA expression pattern
	Top expressed in
	right lobe of liver; ; pancreatic ductal cell; ; blood; ; body of pancreas; ; palpebral conjunctiva; ; bone marrow; ; gallbladder; ; appendix; ; parotid gland; ; bone marrow cells;
	Top expressed in
	left lobe of liver; ; white adipose tissue; ; brown adipose tissue; ; subcutaneous adipose tissue; ; ankle joint; ; ankle; ; right lung lobe; ; interventricular septum; ; thoracic diaphragm; ; myocardium of ventricle;
	More reference expression data
	n/a
Gene ontology
Molecular function	transforming growth factor beta receptor binding ; protein binding ; molecular function ;
Cellular component	extracellular exosome ; membrane ; extracellular space ; specific granule lumen ; intracellular membrane-bounded organelle ; tertiary granule lumen ; ficolin-1-rich granule lumen ; extracellular region ;
Biological process	positive regulation of transforming growth factor beta receptor signaling pathway ; positive regulation of endothelial cell proliferation ; positive regulation of angiogenesis ; brown fat cell differentiation ; neutrophil degranulation ; biological process ; response to bacterium ;
	Sources:Amigo / QuickGO
Orthologs
	116844
	76905
	ENSG00000171236
	ENSMUSG00000037095
	P02750
	Q91XL1
	NM_052972
	NM_029796
	NP_443204
	NP_084072
	Wikidata
View/Edit Human	View/Edit Mouse

Last updated February 12, 2024

Leucine-rich alpha-2-glycoprotein 1 is a protein which in humans is encoded by the gene LRG1.^[5]

Function

The leucine-rich repeat (LRR) family of proteins, including LRG1, have been shown to be involved in protein-protein interaction, signal transduction, and cell adhesion and development. LRG1 is expressed during granulocyte differentiation.^[5]^[6]

LRG1 has been shown to be involved in promoting neovascularization (new blood vessel growth) through causing a switch in transforming growth factor beta (TGFbeta) signaling in endothelial cells. LRG1 binds to the accessory receptor endoglin and promotes signaling via the ALK1-Smad1/5/8 pathway.^[7]

Application

Levels of the LRG protein are markedly elevated in acute appendicitis and therefore could be used as a diagnostic aid.^[8]

LRG1 may be a potential therapeutic target for the treatment of diseases where there is aberrant neovascularization.^[7]

Circulating LRG1 levels are increased in many cancer patients and may be a useful biomarker. Inhibition of LRG1 normalises the tumor vasculature, improves the efficacy of cytotoxic and immune therapies,^[9] and restricts metastatic spread. ^[10]

LRG1 has been implicated in the pathogenesis of numerous diseases including cancer, eye disease, neurodegenerative disease, diabetes, lung and kidney disease^[11]

Related Research Articles

CD146 also known as the melanoma cell adhesion molecule (MCAM) or cell surface glycoprotein MUC18, is a 113kDa cell adhesion molecule currently used as a marker for endothelial cell lineage. In humans, the CD146 protein is encoded by the MCAM gene.

Probable G-protein coupled receptor 124 is a protein that in humans is encoded by the GPR124 gene. It is a member of the adhesion-GPCR family of receptors. Family members are characterized by an extended extracellular region with a variable number of protein domains coupled to a TM7 domain via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain.

Leucine-rich repeat-containing G-protein coupled receptor 6 is a protein that in humans is encoded by the LGR6 gene. Along with the other G-protein coupled receptors LGR4 and LGR5, LGR6 is a Wnt signaling pathway mediator. LGR6 also acts as an epithelial stem cell marker in squamous cell carcinoma in mice in vivo.

Glycoprotein IX (platelet) (GP9) also known as CD42a (Cluster of Differentiation 42a), is a human gene.

Galectin-3-binding protein is a protein that in humans is encoded by the LGALS3BP gene.

CD166 antigen is a 100-105 kD typeI transmembrane glycoprotein that is a member of the immunoglobulin superfamily of proteins. In humans it is encoded by the ALCAM gene. It is also called CD166, MEMD, SC-1/DM-GRASP/BEN in the chicken, and KG-CAM in the rat.

Interferon-induced guanylate-binding protein 1 is a protein that in humans is encoded by the GBP1 gene. It belongs to the dynamin superfamily of large GTPases.

Basal cell adhesion molecule, also known as Lutheran antigen, is a plasma membrane glycoprotein that in humans is encoded by the BCAM gene. BCAM has also recently been designated CD239.

Glycoprotein V (platelet) (GP5) also known as CD42d (Cluster of Differentiation 42d), is a human gene.

Prolactin-inducible protein also known as gross cystic disease fluid protein 15 (GCDFP-15), extra-parotid glycoprotein (EP-GP), gp17seminal actin-binding protein (SABP) or BRST2 is a protein that in humans is encoded by the PIP gene. It is upregulated by prolactin and androgens and downregulated by estrogen.

Elongation factor Tu, mitochondrial is a protein that in humans is encoded by the TUFM gene. It is an EF-Tu homolog.

Lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1), also known as extracellular link domain containing 1 (XLKD1) is a Link domain-containing hyaladherin, a protein capable of binding to hyaluronic acid (HA), homologous to CD44, the main HA receptor. In humans it is encoded by the LYVE1 gene.

CD109 is a human gene.

Inter-alpha-trypsin inhibitor heavy chain H4 is a protein that in humans is encoded by the ITIH4 gene.

Beta-Ala-His dipeptidase is an enzyme that in humans is encoded by the CNDP1 gene.

Acidic leucine-rich nuclear phosphoprotein 32 family member B (ANP32B) also known as "acidic protein rich in leucines" (APRIL) is a protein that in humans is encoded by the ANP32B gene.

Golgi membrane protein 1 (GOLM1) also known as Golgi phosphoprotein 2 or Golgi membrane protein GP73 is a protein that in humans is encoded by the GOLM1 gene. Two alternatively spliced transcript variants encoding the same protein have been described for this gene.

Leucine-rich PPR motif-containing protein, mitochondrial is a protein that in humans is encoded by the LRPPRC gene. Transcripts ranging in size from 4.8 to 7.0 kb which result from alternative polyadenylation have been reported for this gene.

Sodium/potassium-transporting ATPase subunit beta-3 is an enzyme that in humans is encoded by the ATP1B3 gene. ATP1B3 has also been designated as CD298.

IgGFc-binding protein is a protein that in humans is encoded by the FCGBP gene.

References

1 2 3 GRCh38: Ensembl release 89: ENSG00000171236 - Ensembl, May 2017
1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000037095 - Ensembl, May 2017
↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
1 2 "Entrez Gene: LRG1 leucine-rich alpha-2-glycoprotein 1".
↑ O'Donnell LC, Druhan LJ, Avalos BR (September 2002). "Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation". Journal of Leukocyte Biology. 72 (3): 478–485. doi: 10.1189/jlb.72.3.478 . PMID 12223515. S2CID 967662.
1 2 Wang X, Abraham S, McKenzie JA, Jeffs N, Swire M, Tripathi VB, et al. (July 2013). "LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling". Nature. 499 (7458): 306–311. Bibcode:2013Natur.499..306W. doi:10.1038/nature12345. PMC 3836402 . PMID 23868260.
↑ Vargas IM (2009-06-23). "A urine test for appendicitis?". HarvardScience Press Release. Harvard College. Retrieved 2009-06-25.
↑ O'Connor MN, Kallenberg DM, Camilli C, Pilotti C, Dritsoula A, Jackstadt R, et al. (November 2021). "LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency". Med. 2 (11): 1231–1252.e10. doi: 10.1016/j.medj.2021.10.002 . PMC 7614757 . PMID 35590198.
↑ Singhal M, Gengenbacher N, Abdul Pari AA, Kamiyama M, Hai L, Kuhn BJ, et al. (September 2021). "Temporal multi-omics identifies LRG1 as a vascular niche instructor of metastasis". Science Translational Medicine. 13 (609): eabe6805. doi:10.1126/scitranslmed.abe6805. PMC 7614902 . PMID 34516824. S2CID 237402143.
↑ Camilli C, Hoeh AE, De Rossi G, Moss SE, Greenwood J (January 2022). "LRG1: an emerging player in disease pathogenesis". Journal of Biomedical Science. 29 (1): 6. doi: 10.1186/s12929-022-00790-6 . PMC 8781713 . PMID 35062948.

Li X, Miyajima M, Jiang C, Arai H (February 2007). "Expression of TGF-betas and TGF-beta type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus". Neuroscience Letters. 413 (2): 141–144. doi:10.1016/j.neulet.2006.11.039. PMID 17194537. S2CID 54324280.
Ramachandran P, Boontheung P, Xie Y, Sondej M, Wong DT, Loo JA (June 2006). "Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry". Journal of Proteome Research. 5 (6): 1493–1503. doi:10.1021/pr050492k. PMID 16740002.
Cummings C, Walder J, Treeful A, Jemmerson R (July 2006). "Serum leucine-rich alpha-2-glycoprotein-1 binds cytochrome c and inhibits antibody detection of this apoptotic marker in enzyme-linked immunosorbent assay". Apoptosis. 11 (7): 1121–1129. doi:10.1007/s10495-006-8159-3. PMID 16699948. S2CID 39838086.
Liu T, Qian WJ, Gritsenko MA, Camp DG, Monroe ME, Moore RJ, Smith RD (2006). "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry". Journal of Proteome Research. 4 (6): 2070–2080. doi:10.1021/pr0502065. PMC 1850943 . PMID 16335952.
Yamada S, Ohira M, Horie H, Ando K, Takayasu H, Suzuki Y, et al. (August 2004). "Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas". Oncogene. 23 (35): 5901–5911. doi: 10.1038/sj.onc.1207782 . PMID 15221005.
Bunkenborg J, Pilch BJ, Podtelejnikov AV, Wiśniewski JR (February 2004). "Screening for N-glycosylated proteins by liquid chromatography mass spectrometry". Proteomics. 4 (2): 454–465. doi:10.1002/pmic.200300556. PMID 14760718. S2CID 29261009.
Anderson NL, Polanski M, Pieper R, Gatlin T, Tirumalai RS, Conrads TP, et al. (April 2004). "The human plasma proteome: a nonredundant list developed by combination of four separate sources". Molecular & Cellular Proteomics. 3 (4): 311–326. doi: 10.1074/mcp.M300127-MCP200 . PMID 14718574.
O'Donnell LC, Druhan LJ, Avalos BR (September 2002). "Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation". Journal of Leukocyte Biology. 72 (3): 478–485. doi: 10.1189/jlb.72.3.478 . PMID 12223515. S2CID 967662.
Saito K, Tanaka T, Kanda H, Ebisuno Y, Izawa D, Kawamoto S, et al. (February 2002). "Gene expression profiling of mucosal addressin cell adhesion molecule-1+ high endothelial venule cells (HEV) and identification of a leucine-rich HEV glycoprotein as a HEV marker". Journal of Immunology. 168 (3): 1050–1059. doi: 10.4049/jimmunol.168.3.1050 . PMID 11801638.
Takahashi N, Takahashi Y, Putnam FW (April 1985). "Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum". Proceedings of the National Academy of Sciences of the United States of America. 82 (7): 1906–1910. Bibcode:1985PNAS...82.1906T. doi: 10.1073/pnas.82.7.1906 . PMC 397442 . PMID 3856868.
Andersen JD, Boylan KL, Xue FS, Anderson LB, Witthuhn BA, Markowski TW, et al. (January 2010). "Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis". Electrophoresis. 31 (4): 599–610. doi:10.1002/elps.200900441. PMC 3520508 . PMID 20162585.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

This article on a gene on human chromosome 19 is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[refGRCh38Ensembl-1] 1 2 3 GRCh38: Ensembl release 89: ENSG00000171236 - Ensembl, May 2017

[refGRCm38Ensembl-2] 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000037095 - Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[entrez-5] 1 2 "Entrez Gene: LRG1 leucine-rich alpha-2-glycoprotein 1".

[pmid12223515-6] O'Donnell LC, Druhan LJ, Avalos BR (September 2002). "Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation". Journal of Leukocyte Biology. 72 (3): 478–485. doi: 10.1189/jlb.72.3.478 . PMID 12223515. S2CID 967662.

[pmid23868260-7] 1 2 Wang X, Abraham S, McKenzie JA, Jeffs N, Swire M, Tripathi VB, et al. (July 2013). "LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling". Nature. 499 (7458): 306–311. Bibcode:2013Natur.499..306W. doi:10.1038/nature12345. PMC 3836402 . PMID 23868260.

[urlA_urine_test_for_appendicitis?_|_HarvardScience-8] Vargas IM (2009-06-23). "A urine test for appendicitis?". HarvardScience Press Release. Harvard College. Retrieved 2009-06-25.

[https://doi.org/10.1016/j.medj.2021.10.002-9] O'Connor MN, Kallenberg DM, Camilli C, Pilotti C, Dritsoula A, Jackstadt R, et al. (November 2021). "LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency". Med. 2 (11): 1231–1252.e10. doi: 10.1016/j.medj.2021.10.002 . PMC 7614757 . PMID 35590198.

[PMID:34516824-10] Singhal M, Gengenbacher N, Abdul Pari AA, Kamiyama M, Hai L, Kuhn BJ, et al. (September 2021). "Temporal multi-omics identifies LRG1 as a vascular niche instructor of metastasis". Science Translational Medicine. 13 (609): eabe6805. doi:10.1126/scitranslmed.abe6805. PMC 7614902 . PMID 34516824. S2CID 237402143.

[11] Camilli C, Hoeh AE, De Rossi G, Moss SE, Greenwood J (January 2022). "LRG1: an emerging player in disease pathogenesis". Journal of Biomedical Science. 29 (1): 6. doi: 10.1186/s12929-022-00790-6 . PMC 8781713 . PMID 35062948.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

LRG1

Contents

Function

Application

Related Research Articles

References

Further reading